Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26570580 | 0.90 | PRKCA (0.46) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL26570576 | 0.90 | PRKCA (0.46) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL26570587 | 0.90 | PRKCA (0.46) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL26571070 | 0.87 | PRKCA (0.40) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL26570600 | 0.86 | PRKCA (0.53) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL26570596 | 0.86 | PRKCA (0.53) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL26570569 | 0.81 | PRKCA (0.40) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL24390151 | 0.79 | PRKCA (0.36) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL24390136 | 0.78 | PRKCA (0.34) | PRKCAPRKCEPRKCQPRKCDKDM4E | |
| SCHEMBL24390144 | 0.78 | PRKCA (0.34) | PRKCAPRKCEPRKCQPRKCDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230323031-A1 | POLYMER COMPRISING A PLURALITY OF ACTIVE AMINE GROUPS, RELATED POLYMERS AND RELATED METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230323031-A1 | POLYMER COMPRISING A PLURALITY OF ACTIVE AMINE GROUPS, RELATED POLYMERS AND RELATED METHODS THEREOF | PARG, PARN, PAM | PRKCA 2611/4885PRKCE 2074/4885PRKCQ 1872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.